Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | TECH | KRYS | ||
| Company | Arrowhead Pharma | Bio-Techne Corp | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 63.31 | 58.55 | 286.67 | ||
| High | 65.59 | 59.68 | 290.31 | ||
| Low | 63.19 | 57.92 | 277.77 | ||
| Latest | 64.38 | 59.33 | 283.29 | ||
| Change | +0.69 | +0.83 | -4.55 | ||
| % Change | +1.08% | +1.42% | -1.58% | ||
| Volume | 1,642,600 | 1,836,300 | 525,400 | ||
| 20-Day Average Volume | 3,540,535 | 2,576,060 | 291,700 | ||
| Previous Close | 63.69 | 58.50 | 287.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 66.29 | 65.04 | 277.47 | ||
| 20-Day Raw Stochastic | 25.62% | 9.90% | 62.43% | ||
| 20-Day Relative Strength | 50.12 | 41.30 | 59.83 | ||
| Weighted Alpha | +213.18 | -5.38 | +79.13 | ||
| Today's Opinion | 40% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 40% Buy | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.32% since 02/10/26 | -8.44% since 02/10/26 | +4.65% since 02/10/26 | ||
| Low | 60.34 on 02/11/26 | 57.92 on 02/18/26 | 264.85 on 02/11/26 | ||
| High | 65.59 on 02/18/26 | 64.78 on 02/11/26 | 298.30 on 02/17/26 | ||
| 1-Month | |||||
| %Chg | +0.85% since 01/16/26 | -13.60% since 01/16/26 | -0.61% since 01/16/26 | ||
| Low | 60.34 on 02/11/26 | 57.92 on 02/18/26 | 258.34 on 02/04/26 | ||
| High | 76.11 on 02/03/26 | 72.16 on 01/22/26 | 298.30 on 02/17/26 | ||
| 3-Month | |||||
| %Chg | +59.08% since 11/18/25 | +2.03% since 11/18/25 | +38.37% since 11/18/25 | ||
| Low | 37.06 on 11/20/25 | 56.59 on 12/16/25 | 203.17 on 11/20/25 | ||
| High | 76.76 on 01/06/26 | 72.16 on 01/22/26 | 298.30 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +223.36% since 08/18/25 | +11.33% since 08/18/25 | +93.64% since 08/18/25 | ||
| Low | 19.42 on 08/19/25 | 50.13 on 09/25/25 | 136.73 on 09/10/25 | ||
| High | 76.76 on 01/06/26 | 72.16 on 01/22/26 | 298.30 on 02/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,918,637 | 9,152,501 | 8,346,781 | ||
| Shares Outstanding, K | 140,032 | 156,453 | 28,998 | ||
| Annual Sales | 829,450,000 | 1,219,640,000 | 290,520,000 | ||
| Annual Net Income | -1,630,000 | 73,400,000 | 89,160,000 | ||
| Last Quarter Sales | 264,030,000 | 295,880,000 | 97,800,000 | ||
| Last Quarter Net Income | 30,810,000 | 38,010,000 | 79,370,000 | ||
| 60-Month Beta | 1.21 | 1.48 | 0.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 02/05/26 | 0.46 on 02/04/26 | 1.70 on 02/17/26 | ||
| Latest Earnings Date | 05/11/26 | 05/06/26 | 02/17/26 | ||
| Most Recent Dividend | N/A | 0.080 on 02/13/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/13/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 41.71 | 34.05 | 41.45 | ||